Models using EHR data from infants in NICU can detect sepsis hours before clinical signs are apparent.
While sepsis was the most common immediate cause of death at 6 US academic and community hospitals, most patients had severe chronic comorbidities.
Staphylococcus aureus infections are still a concern in the United States, despite a decline seen in hospital-onset MRSA infections since 2005.
Readmission after sepsis hospitalization is common and is associated with considerable costs.
A new sepsis screening tool developed using machine learning was timelier and more discriminating than several benchmark screening tools.
A blood test that can quickly diagnose dangerous sepsis infections has been developed.
The incidence of pneumococcal sepsis in children remained substantial after the introduction of the pneumococcal conjugate vaccine in Switzerland.
A low level of LDL cholesterol was initially associated with increased risk for sepsis and admission to the ICU.
Practices vary among clinicians in diagnosing and managing Staphylococcus aureus bacteremia in adults.
Using a single-family room setting significantly reduced neonatal sepsis and improved breastfeeding rates at discharge.
The administration of corticosteroids in patients with sepsis may be associated with significant improvement in patient outcomes.
80 to 90% pathogen coverage was acceptable to physicians as a threshold for managing patients with mild and severe sepsis from bacterial infections.
Patients diagnosed with community-acquired pneumonia with higher levels of fibroblast growth factor-21 may have higher mortality rates and longer hospitalizations.
Investigators identified risk factors for repeat surgical intervention after initial arthrotomy for presumed septic arthritis of the hip.
Early administration of IV fluids by paramedics to patients with sepsis was linked with lower mortality, but only in patients with low initial systolic BP.
Crowding in the emergency department was associated with the timely administration of antibiotics for patients presenting with sepsis.
For patients with septic shock and high circulating endotoxin levels, adding polymyxin B hemoperfusion treatment did not improve 28-day mortality rate.
Excessive numbers of negative clinical trials — many of which may be false-negative trials — are a major impediment to the advancement of critical care medicine.
Sepsis associated with treatment for acute lymphoblastic leukemia in pediatric patients can affect long-term neurocognitive function.
Antibiotic treatment started sooner in individuals with sepsis treated with advanced life support who did not have hypotension.